The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis

Charité - Universitätsmedizin Berlin, Berlin

Children's Hospital of Philadelphia (CHOP), Philadelphia

Katholisches Kinderkrankenhaus Wilhelmstift GmbH, Hamburg

Pariser Dermatology Specialists, Norfolk

Wake Forest University Health Sciences, Winston-Salem

Medical University of South Carolina, Charleston

Hopital Larrey CHU Toulouse, Toulouse

University of Miami, Dermatology Clinical Trial Unit, Miami

University of Mississippi Medical Center (UMMC) - Face and Skin Center, Ridgeland

CHU de Nantes Hotel Dieu, Nantes

The Indiana Clinical Trials Center (Optima Research), Boardman

The Indiana Clinical Trials Center (Optima Research), Plainfield

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

Münster University Hospital, Münster

Ambulatorio di Malattie Rare Dermatologiche e Immunopatologia Cutanea, Florence

Steven Kempers, New Brighton

Northwestern University - Feinberg School of Medicine - Dermatology Department, Chicago

Hôpital Femme Mère Enfant, Bron

U.O. di Dermatologia e Venereologia Universitaria, Bari

Hopital Necker APHP, Paris

Austin Institute for Clinical Research, Houston

Austin Institute for Clinical Research, Inc., Pflugerville

About Skin Dermatology, Centennial

Medical Dermatology Specialists (US Derm Partners), Phoenix

Universitätsklinikum Erlangen, Erlangen

Stanford Children's Health, Palo Alto

North Sound Dermatology, Mill Creek

Yale Dermatology, Middlebury

Stollery children's hospital, Edmonton

Dr. Chih-ho Hong Medical Inc., Surrey

Wiseman Dermatology Research Inc., Winnipeg

Sickkids Hospital, Toronto, Canada, Toronto

Ambulatorio Malattie Rare IRCCS Sant'Orsola, Bologna

U.O.C. di Dermatologia Dipartimento Pediatrico Universitario Ospedaliero, Roma